Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LAIR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LILRA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LILRA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTYH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LENG8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LENG9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC42EP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRB5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRA6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAIR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIR3DX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on